Search

Your search keyword '"Kokkola, Tarja"' showing total 262 results

Search Constraints

Start Over You searched for: Author "Kokkola, Tarja" Remove constraint Author: "Kokkola, Tarja"
262 results on '"Kokkola, Tarja"'

Search Results

1. Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study

3. Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits

4. A FinnGen pilot clinical recall study for Alzheimer’s disease

5. Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models

6. Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models

7. Author Correction: Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models

8. Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype

9. TWINGEN: protocol for an observational clinical biobank recall and biomarker cohort study to identify Finnish individuals with high risk of Alzheimer’s disease

11. Dietary metabolite profiling brings new insight into the relationship between nutrition and metabolic risk: An IMI DIRECT study

13. Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration

14. The Association of Cardiometabolic, Diet and Lifestyle Parameters With Plasma Glucagon-like Peptide-1: An IMI DIRECT Study

15. Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium

16. Cerebrospinal Fluid Diagnostics of Alzheimer’s Disease in Patients with Idiopathic Normal Pressure Hydrocephalus

17. Whole blood co-expression modules associate with metabolic traits and type 2 diabetes: an IMI-DIRECT study

18. Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalus

19. Serum Cathepsin S Levels Do Not Show Alterations in Different Clinical, Neuropathological, or Genetic Subtypes of Frontotemporal Dementia Patients nor in Comparison to Healthy Control Individuals

21. A FinnGen pilot clinical recall study for Alzheimer’s disease

22. Concordance of Alzheimer’s Disease-Related Biomarkers Between Intraventricular and Lumbar Cerebrospinal Fluid in Idiopathic Normal Pressure Hydrocephalus

24. Protective Alzheimer’s disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models

27. Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study

28. Oxygen-18 and carbon-13 isotopes in eCO(2) and erythrocytes carbonic anhydrase activity of Finnish prediabetic population

29. Inferring causal pathways between metabolic processes and liver fat accumulation: an IMI DIRECT study

30. Profiles of Glucose Metabolism in Different Prediabetes Phenotypes, Classified by Fasting Glycemia, 2-Hour OGTT, Glycated Hemoglobin, and 1-hour OGTT: An IMI DIRECT Study

31. Correction to: The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI DIRECT study (Diabetologia, (2020), 63, 4, (744-756), 10.1007/s00125-019-05083-6)

32. Profiles of glucose metabolism in different prediabetes phenotypes, classified by fasting glycemia, 2-hour OGTT, glycated hemoglobin, and 1-hour OGTT:An IMI DIRECT study

33. Processes Underlying Glycemic Deterioration in Type 2 Diabetes:An IMI DIRECT Study

35. GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance

36. The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI DIRECT study

37. Predicting and elucidating the etiology of fatty liver disease:A machine learning modeling and validation study in the IMI DIRECT cohorts

38. Additional file 1 of Whole blood co-expression modules associate with metabolic traits and type 2 diabetes: an IMI-DIRECT study

39. Additional file 2 of Whole blood co-expression modules associate with metabolic traits and type 2 diabetes: an IMI-DIRECT study

40. Dietary metabolite profiling brings new insight into the relationship between nutrition and metabolic risk:An IMI DIRECT study

41. The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes:an IMI DIRECT study

42. The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI DIRECT study

43. Whole blood co-expression modules associate with metabolic traits and type 2 diabetes:an IMI-DIRECT study

44. Post-load glucose subgroups and associated metabolic traits in individuals with type 2 diabetes:An IMI-DIRECT study

46. Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study

47. Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts

49. Predicting and elucidating the etiology of fatty liver disease using a machine learning-based approach: an IMI DIRECT study

50. Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration

Catalog

Books, media, physical & digital resources